ESG is Everyone’s Business at Teva
Our 2021 Environmental, Social and Governance (ESG) Progress Report shares our efforts to strengthen the connection between ESG and our business, and outlines how we’re holding ourselves accountable to future progress.
Biosimilars are advancing more treatment options for patients’
Cory Wohlbach is responsible for steering Teva’s new biosimilar products through the regulatory approval process. He explains how biosimilars have the potential to reduce costs and that patient safety is always a top priority.
Take a closer look at Teva
Environmental, Social and Governance (ESG)
Action & Accountability: Highlights of Teva’s ESG Progress
As a company focused on improving the health of patients everywhere, impact has always been central to Teva. This comes to life through our Environmental, Social and Governance (ESG) strategy, which guides us in minimizing our impact on the planet, advancing health and equity and dedicating ourselves to quality, ethics and transparency.
Careers at Teva
Dynamic. Diverse. Dedicated. Be Part of the Teva Team
At Teva, we strive to make a difference in the lives of people around the world each and every day.